Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integration of ζ-deficient CARs into the CD3 ζ gene conveys potent cytotoxicity in T and NK cells
Jonas Kath, Clemens Franke, Vanessa Drosdek, et al.
Blood (2024) Vol. 143, Iss. 25, pp. 2599-2611
Open Access | Times Cited: 14

Showing 14 citing articles:

Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy
Tao Lei, Yazhuo Wang, Yuchen Zhang, et al.
Leukemia (2024)
Open Access | Times Cited: 16
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
Tobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
Mohamed Abou‐El‐Enein
Blood Cancer Discovery (2024) Vol. 5, Iss. 4, pp. 249-257
Closed Access | Times Cited: 8
Revisiting the need for mRNA nucleoside modification in CAR T cell engineering
Nourhan Kahwaji, Niklas Kotzian, Jörg C. Prinz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security?
Xueshuai Ye, Min Ge, M. Tan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs
Guo Shu-hua, Xiaozhi Xi
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy
Ana Hinckley-Boned, Carmen Barbero-Jiménez, María Tristán‐Manzano, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010702-e010702
Open Access
Optimizing viral transduction in immune cell therapy manufacturing: key process design considerations
Liu Dan, Lee Kang-Zheng
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Synthetic Cells and Molecules in Cellular Immunotherapy
Haikun Lin, Chentao Li, Wanying Zhang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 2833-2859
Open Access | Times Cited: 1
CAR-T cell therapy : recent updates and challenges in autoimmune diseases
Blandine Caël, Elodie Bôle‐Richard, Francine Garnache‐Ottou, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 1
Current Non-Viral-Based Strategies to Manufacture CAR-T Cells
Leon Gehrke, Vasco Dos Reis Gonçalves, Dominik Andrae, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13685-13685
Open Access | Times Cited: 1
Empowering virus-free CAR immune cell therapies
Tobias Bexte, Evelyn Ullrich
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1609-1611
Closed Access
Putting together the pieces: CAR into CD3ζ locus
Monica Casucci
Blood (2024) Vol. 143, Iss. 25, pp. 2562-2564
Closed Access
Robust and cost‐effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ‐TCL1 model of chronic lymphocytic leukemia
Rosita Del Prete, Roberta Drago, Federica Nardi, et al.
HemaSphere (2024) Vol. 8, Iss. 8
Open Access
Page 1

Scroll to top